134 related articles for article (PubMed ID: 27444107)
1. Variation in the Use of Chemoradiotherapy for Stage II and III Anal Cancer: Analysis of the National Cancer Data Base.
Geltzeiler CB; Tsikitis VL; Kim JS; Thomas CR; Herzig DO; Lu KC
Ann Surg Oncol; 2016 Nov; 23(12):3934-3940. PubMed ID: 27444107
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.
Bian SX; Chen DH; Lin E
Cancer Med; 2021 Jan; 10(2):575-585. PubMed ID: 33305908
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
5. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
7. Patterns of care for anal cancer in the United States - a comparison between academic and community cancer centers.
Pricolo VE; Bonvini M; Abelli CF
BMC Cancer; 2018 May; 18(1):567. PubMed ID: 29769057
[TBL] [Abstract][Full Text] [Related]
8. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
9. Does race impact survival for patients with anal squamous cell carcinoma?
Fields AC; Welten VM; Lu P; Goldberg JE; Irani J; Bleday R; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1201-1207. PubMed ID: 31549446
[TBL] [Abstract][Full Text] [Related]
10. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
11. [Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal].
Karasawa H; Ohnuma S; Watanabe K; Tsuchiya T; Imoto H; Aoki T; Kudoh K; Tanaka N; Nagao M; Abe T; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2009-2010. PubMed ID: 29394850
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
Elson JK; Kachnic LA; Kharofa JR
Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
[TBL] [Abstract][Full Text] [Related]
13. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base.
Geltzeiler CB; Nabavizadeh N; Kim J; Lu KC; Billingsley KG; Thomas CR; Herzig DO; Tsikitis VL
Ann Surg Oncol; 2014 Oct; 21(11):3616-20. PubMed ID: 24943237
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
16. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
17. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
18. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
19. Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012).
Kim E; Kim JS; Choi M; Thomas CR
Dis Colon Rectum; 2016 Apr; 59(4):291-8. PubMed ID: 26953987
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]